![]() |
by Adam J. Fein, Ph.D. (134 page downloadable PDF file; Released January 2012) The 2011-12 Economic Report on Retail and Specialty Pharmacies is an invaluable planning tool for pharmaceutical manufacturers, pharmacists, employers, benefit managers, managed care executives, healthcare policy analysts, investors—anyone who wants to understand and benefit from the forces reshaping the increasingly competitive U.S. pharmacy industry. It provides the most comprehensive look at the economics and trends behind the $275 billion pharmacy industry. Single-User License: $380 Corporate License: $1,090 |
![]() |
by Adam J. Fein, Ph.D. (126 page downloadable PDF file; Released September 2011) The $300 billion U.S. drug wholesaling industry is evolving faster than ever. The biggest wholesalers are positioning themselves as indispensable intermediaries in the supply chain and staking out a powerful position in high-growth channels for specialty drugs. Understanding the implications of this industry’s evolution has never been more crucial. Single-User License: $340 Corporate License: $980 |